BIO Web Conf.
Volume 14, 2019The 12th International Conference on the Health Effects of Incorporated Radionuclides (HEIR 2018)
|Number of page(s)||2|
|Section||Nuclear Medicine, Targeted Therapy and Medical Imaging: Oral presentations|
|Published online||07 May 2019|
Radio-iodine therapy of Graves’ disease: is there a dose-effect relationship?
IRSN, IRSN/SDOS/LEDI, BP-17, 92626 Fontenay-aux-Roses, France
1 Corresponding author: email@example.com
Graves’ disease is a benign disease very often treated with radioiodine , its incidence is about 30/100 000/year in Europe and USA . Even if several millions of radioiodine treatments have been administrated  there are still debates on the exact amount of iodine that should be administrated and on the final goal of the therapy: permanently hypothyroid or euthyroid [3-4].
Fitted dose-effect relationship: success rate as a function of thyroid dose.
Inspection of the literature shows that there are little evidences for choosing the requested thyroid dose. In order to obtain the dose-effect relationship for the success of iodine-131 therapy for Grave’s disease we carried out an analysis of the literature.
We looked for literature data reporting the success of a single I-131 therapy for Grave’s disease. We only included peer-reviewed articles in French or German where the thyroid dose was reported along with the success rate.
We assigned an uncertainty to the success rate (exact Cloper-Pearson method) and to the reported dose. We finally carried out a fit of the data using, as an ansatz, a sigmoid function. In the fitting procedure both error bars were taken into account following the method of Wolberg .
We extracted from the literature 22 relevant papers accounting for a total of 3922 patients. The reported thyroid doses were between 60 and 649 Gy. In all studies the thyroid dose was calculated with at least one uptake measurement and an ultrasound assessment of the thyroid weight. In 15 of the studies the dose uncertainty was reported or could be deduced. An average dose uncertainty of 26% was fixed for the other studies.
The resulting fitted dose-effect relationship is shown in figure 1. The data supporting the fit are relatively scattered. However, the fitting procedure naturally produces and average trend and the associated 95% confidence band. The fitted result is in very good agreement with the 1995 data of Peters  which were obtained with 98 patients (data not shown).
According to our findings the confidence bands for therapy success are as follows: [55-80%] at 150Gy, [65-90%] at 200Gy and [80-95%] at 300Gy.
Several factors can explain the scattered pattern of the obtained data: large uncertainties on axes, different follow-up periods, different regimen of medication withdrawal before therapy. Surprisingly, such a scattered pattern can also be found in multi-centre studies in external radiotherapy.
To the best of our knowledge this work is the more exhaustive and complete analysis of the dose-effect relationship for one of the most common radio-iodine therapy. On one hand, if one assumes that the data and analysis are reliable it should be concluded that there is no real dose-effect relationship. One the other hand, assuming that a dose effect relationship must exist, it should be concluded that in future studies the dose assessment should be more accurate, using for example several uptake measurements, and that follow-up times and inclusion criteria chosen more rigorously.
- Bonnema S.J and Hegedüs L. Endocrine Reviews, 33 (6): 920-980 (2012). [CrossRef] [PubMed] [Google Scholar]
- McLeod D.S.A. and Cooper D.S. Endocrine 42 (2): 252-265 (2012) [CrossRef] [PubMed] [Google Scholar]
- Van Isselt J.W et al. European Journal of Nuclear Medicine and Molecular Imaging 34 (11):1883-1884 (2007) [CrossRef] [PubMed] [Google Scholar]
- Kalinyak J.E. and McDougall I.R. Journal of Clinical Endocrinology and Metabolism 88(3):975-977 (2003). [CrossRef] [Google Scholar]
- Wolberg J. Data Analysis Using the Method of Least Squares, 2006, Springer [Google Scholar]
- Peters H. et al. European Journal of Clinical Investigation 25 (3): 186-193 (1995). [CrossRef] [PubMed] [Google Scholar]
© The Authors, published by EDP Sciences, 2019
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Initial download of the metrics may take a while.